The Lancet Respiratory Medicine 今日热榜-jinrirebang.top



The Lancet Respiratory Medicine The Lancet Respiratory Medicine

1.	[Correspondence] The persistent mismeasure of spirometry in women	Philippe Haouzi, Johnathan McCully	
2.	[Corrections] Correction to Lancet Respir Med 2023; 11: 1064–74		
3.	[Editorial] Lung transplant donors: barriers and ethical considerations	The Lancet Respiratory Medicine	
4.	[Correspondence] Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway	Nhung TH Trinh, Annika M Jödicke, Martí Català, Núria Mercadé-Besora, Saeed Hayati, Angela Lupattelli, Daniel Prieto-Alhambra, Hedvig ME Nordeng	
5.	[Spotlight] UK patient with multidrug-resistant tuberculosis	Tony Kirby	
6.	[Comment] “Yes! We can end TB,” but remember the sequelae in children	Esin Nkereuwem, Marieke M van der Zalm, Beate Kampmann, Toyin Togun	
7.	[Comment] Genetic factors for ILD—the path of precision medicine	Ganesh Raghu, Juliet M Torres, Robin L Bennett	
8.	[Articles] Association of active mobilisation variables with adverse events and mortality in patients requiring mechanical ventilation in the intensive care unit: a systematic review and meta-analysis	Michelle Paton, Sarah Chan, Ary Serpa Neto, Claire J Tipping, Anne Stratton, Rebecca Lane, Lorena Romero, Tessa Broadley, Carol L Hodgson	
9.	[Comment] Early mobilisation in the intensive care unit: shifting from navigating risks to a patient-centred approach	Hannah Wozniak, Michelle E Kho, Eddy Fan	
10.	[Comment] MACE in COPD: addressing cardiopulmonary risk	John R Hurst, Chris P Gale, Global Working Group on Cardiopulmonary Risk	
11.	[Comment] Corticosteroids in septic shock secondary to community acquired pneumonia: clarity mixed with uncertainty	Balasubramanian Venkatesh, Jeremy Cohen	
12.	[Articles] Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial	Nicholas Heming, Alain Renault, Emmanuelle Kuperminc, Christian Brun-Buisson, Bruno Megarbane, Jean-Pierre Quenot, Shidasp Siami, Alain Cariou, Xavier Forceville, Carole Schwebel, Marc Leone, Jean-Francois Timsit, Benoît Misset, Mohamed Ali Benali, Gwenhael Colin, Bertrand Souweine, Karim Asehnoune, Emmanuelle Mercier, Loïc Chimot, Claire Charpentier, Bruno François, Thierry Boulain, Frank Petitpas, Jean Michel Constantin, Gilles Dhonneur, François Baudin, Alain Combes, Julien Bohé, Jean-François Loriferne, Fabrice Cook, Michel Slama, Olivier Leroy, Gilles Capellier, Auguste Dargent, Tarik Hissem, Rania Bounab, Virginie Maxime, Pierre Moine, Eric Bellissant, Djillali Annane, APROCCHSS investigators, CRICS-TRIGGERSEP network	
13.	[Articles] First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial	Hua Zhong, Shengjie Sun, Jianhua Chen, Ziping Wang, Yanqiu Zhao, Guojun Zhang, Gongyan Chen, Ming Zhou, Jianying Zhou, Yingying Du, Lin Wu, Zhi Xu, Xiaodong Mei, Weidong Zhang, Jingdong He, Jiuwei Cui, Zhihong Zhang, Hui Luo, Weiyou Liu, Meili Sun, Jingxun Wu, Yongchun Shen, Shucai Zhang, Nong Yang, Mengzhao Wang, Junguo Lu, Kai Li, Weirong Yao, Qian Sun, Hongmei Yue, Lin Wang, Sheng Ye, Bin Li, Xibin Zhuang, Yueyin Pan, Min Zhang, Yongqian Shu, Zhiyong He, Lei Pan, Yang Ling, Shengming Liu, Qi Zhang, Shunchang Jiao, Baohui Han	
14.	[Articles] Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial	Yin Mo, Suchart Booraphun, Andrew Yunkai Li, Pornanan Domthong, Gyan Kayastha, Yie Hui Lau, Ploenchan Chetchotisakd, Direk Limmathurotsakul, Paul Anantharajah Tambyah, Ben S Cooper, REGARD-VAP investigators	
15.	[Comment] Optimising antibiotic treatment duration in ventilator-associated pneumonia	Emma D Johnson, James D Chalmers	
16.	[Articles] Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial	Claire Dahyot-Fizelier, Sigismond Lasocki, Thomas Kerforne, Pierre-Francois Perrigault, Thomas Geeraerts, Karim Asehnoune, Raphaël Cinotti, Yoann Launey, Vincent Cottenceau, Marc Laffon, Thomas Gaillard, Matthieu Boisson, Camille Aleyrat, Denis Frasca, Olivier Mimoz, PROPHY-VAP Study Group and the ATLANREA Study Group	
17.	[Comment] Antibiotic prophylaxis for patients with acute brain injury	Michael Klompas	
18.	[Position Paper] High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study	Sujal R Desai, Nishanth Sivarasan, Kerri A Johannson, Peter M George, Daniel A Culver, Anand Devaraj, David A Lynch, David Milne, Elisabetta Renzoni, Hilario Nunes, Nicola Sverzellati, Paolo Spagnolo, Robert P Baughman, Ruchi Yadav, Sara Piciucchi, Simon L F Walsh, Vasileios Kouranos, Athol U Wells, Sarcoid Delphi Group	

更新于 38 分钟前

近期历史最近 100 条记录

2024-05-01	[Correspondence] The persistent mismeasure of spirometry in women	Philippe Haouzi, Johnathan McCully	
2024-05-01	[Corrections] Correction to Lancet Respir Med 2023; 11: 1064–74		
2024-05-01	[Editorial] Lung transplant donors: barriers and ethical considerations	The Lancet Respiratory Medicine	
2024-05-01	[Correspondence] Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway	Nhung TH Trinh, Annika M Jödicke, Martí Català, Núria Mercadé-Besora, Saeed Hayati, Angela Lupattelli, Daniel Prieto-Alhambra, Hedvig ME Nordeng	
2024-05-01	[Spotlight] UK patient with multidrug-resistant tuberculosis	Tony Kirby	
2024-05-01	[Comment] “Yes! We can end TB,” but remember the sequelae in children	Esin Nkereuwem, Marieke M van der Zalm, Beate Kampmann, Toyin Togun	
2024-05-01	[Comment] Genetic factors for ILD—the path of precision medicine	Ganesh Raghu, Juliet M Torres, Robin L Bennett	
2024-05-01	[Articles] Association of active mobilisation variables with adverse events and mortality in patients requiring mechanical ventilation in the intensive care unit: a systematic review and meta-analysis	Michelle Paton, Sarah Chan, Ary Serpa Neto, Claire J Tipping, Anne Stratton, Rebecca Lane, Lorena Romero, Tessa Broadley, Carol L Hodgson	
2024-05-01	[Comment] Early mobilisation in the intensive care unit: shifting from navigating risks to a patient-centred approach	Hannah Wozniak, Michelle E Kho, Eddy Fan	
2024-05-01	[Comment] MACE in COPD: addressing cardiopulmonary risk	John R Hurst, Chris P Gale, Global Working Group on Cardiopulmonary Risk	
2024-05-01	[Comment] Corticosteroids in septic shock secondary to community acquired pneumonia: clarity mixed with uncertainty	Balasubramanian Venkatesh, Jeremy Cohen	
2024-05-01	[Articles] Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial	Nicholas Heming, Alain Renault, Emmanuelle Kuperminc, Christian Brun-Buisson, Bruno Megarbane, Jean-Pierre Quenot, Shidasp Siami, Alain Cariou, Xavier Forceville, Carole Schwebel, Marc Leone, Jean-Francois Timsit, Benoît Misset, Mohamed Ali Benali, Gwenha	
2024-05-01	[Articles] First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial	Hua Zhong, Shengjie Sun, Jianhua Chen, Ziping Wang, Yanqiu Zhao, Guojun Zhang, Gongyan Chen, Ming Zhou, Jianying Zhou, Yingying Du, Lin Wu, Zhi Xu, Xiaodong Mei, Weidong Zhang, Jingdong He, Jiuwei Cui, Zhihong Zhang, Hui Luo, Weiyou Liu, Meili Sun, Jingxu	
2024-05-01	[Articles] Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial	Yin Mo, Suchart Booraphun, Andrew Yunkai Li, Pornanan Domthong, Gyan Kayastha, Yie Hui Lau, Ploenchan Chetchotisakd, Direk Limmathurotsakul, Paul Anantharajah Tambyah, Ben S Cooper, REGARD-VAP investigators	
2024-05-01	[Comment] Optimising antibiotic treatment duration in ventilator-associated pneumonia	Emma D Johnson, James D Chalmers	
2024-05-01	[Articles] Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial	Claire Dahyot-Fizelier, Sigismond Lasocki, Thomas Kerforne, Pierre-Francois Perrigault, Thomas Geeraerts, Karim Asehnoune, Raphaël Cinotti, Yoann Launey, Vincent Cottenceau, Marc Laffon, Thomas Gaillard, Matthieu Boisson, Camille Aleyrat, Denis Frasca, Ol	
2024-05-01	[Comment] Antibiotic prophylaxis for patients with acute brain injury	Michael Klompas	
2024-05-01	[Position Paper] High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study	Sujal R Desai, Nishanth Sivarasan, Kerri A Johannson, Peter M George, Daniel A Culver, Anand Devaraj, David A Lynch, David Milne, Elisabetta Renzoni, Hilario Nunes, Nicola Sverzellati, Paolo Spagnolo, Robert P Baughman, Ruchi Yadav, Sara Piciucchi, Simon	
2024-03-27	[Comment] Retraction and republication—Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study	The Editors of The Lancet Respiratory Medicine	
2024-03-27	[Comment] MERIT reloaded—what has changed in CTEPH management since 2017?	Adam Torbicki, Marcin Kurzyna	
2024-03-27	[Articles] Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study	Hossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, Peter Fedullo, Luke S Howard, Xavier Jaïs, David P Jenkins, Zhi-Cheng Jing, Michael M Madani, Nicolas Martin, Eckhard Mayer, Kelly Papadakis, Dominik Richard, Nick H Kim, MERIT study investi	
2024-03-27	[Editorial] Ending tuberculosis: ways forward	The Lancet Respiratory Medicine	
2024-03-27	[Comment] Improving rural intensive care infrastructure in the USA	Tarun Ramesh, Michael Klompas, Hao Yu	
2024-03-27	[Comment] Charting a course for precision therapy trials in sepsis	Robert B Lindell, Nuala J Meyer	
2024-03-27	[News] US CDC plans to relax COVID-19 isolation guidelines	Bryant Furlow	
2024-03-27	[Correspondence] Trouble with promoting lung cancer screening in never-smokers – Authors' reply	Chao-Hua Chiu, Chong-Jen Yu, Gee-Chen Chang, Pan-Chyr Yang	
2024-03-27	[Correspondence] Community-acquired pneumonia: the best candidates for clarithromycin	Yiran Xu, Yun Cai	
2024-03-27	[Correspondence] Community-acquired pneumonia: the best candidates for clarithromycin – Authors' reply	Evangelos J Giamarellos-Bourboulis, Michael S Niederman	
2024-03-27	[Correspondence] Trouble with promoting lung cancer screening in never-smokers	Wayne Gao, H Gilbert Welch	
2024-03-27	[Corrections] Correction to Lancet Respir Med 2024; 12: 181		
2024-03-27	[Personal View] Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies	Manu Shankar-Hari, Thierry Calandra, Miguel P Soares, Michael Bauer, W Joost Wiersinga, Hallie C Prescott, Julian C Knight, Kenneth J Baillie, Lieuwe D J Bos, Lennie P G Derde, Simon Finfer, Richard S Hotchkiss, John Marshall, Peter J M Openshaw, Christop	
2024-03-27	[Corrections] Correction to Lancet Respir Med 2024; 12: 129–40		
2024-03-27	[News] US EPA strengthens PM2·5 air pollution limits	Bryant Furlow	
2024-03-27	[Corrections] Correction to Lancet Respir Med 2024; published online Jan 3. https://doi.org/10.1016/S2213-2600(23)00412-5		
2024-03-27	[News] Tuberculosis, conflict, and displacement	Talha Burki	
2024-03-27	[Comment] Transitioning to gaseous and liquid fuels: a right step towards clean cooking in low-income and middle-income countries	Anindita Dutta, Christopher O Olopade	
2024-03-27	[Articles] Estimated health effects from domestic use of gaseous fuels for cooking and heating in high-income, middle-income, and low-income countries: a systematic review and meta-analyses	Elisa Puzzolo, Nigel Fleeman, Federico Lorenzetti, Fernando Rubinstein, Yaojie Li, Ran Xing, Guofeng Shen, Emily Nix, Michelle Maden, Rebecca Bresnahan, Rui Duarte, Lydia Abebe, Jessica Lewis, Kendra N Williams, Heather Adahir-Rohani, Daniel Pope	
2024-03-27	[Comment] Health effects of gas fuels: interpreting evidence from a comprehensive meta-analysis	John Norrie	
2024-03-27	[News] US Senate committee investigates asthma inhaler prices	Bryant Furlow	
2024-03-27	[Comment] Opioids bring peace to patients with IPF cough	Dominic L Sykes, Simon P Hart	
2024-03-27	[Articles] Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial	Zhe Wu, Lisa G Spencer, Winston Banya, John Westoby, Veronica A Tudor, Pilar Rivera-Ortega, Nazia Chaudhuri, Ira Jakupovic, Brijesh Patel, Muhunthan Thillai, Alex West, Marlies Wijsenbeek, Toby M Maher, Jacky A Smith, Philip L Molyneaux	
2024-03-27	[News] Australia bans engineered stone to prevent silicosis	Tony Kirby	
2024-03-27	[Articles] Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial	Evangelos J Giamarellos-Bourboulis, Athanasios Siampanos, Amalia Bolanou, Sarantia Doulou, Nikolaos Kakavoulis, Konstantinos Tsiakos, Sokratis Katopodis, Georgios Schinas, Lamprini Skorda, Zoi Alexiou, Konstantinos Armenis, Paraskevi Katsaounou, George Ch	
2024-03-27	[Comment] Macrolides in community-acquired pneumonia	Grant Waterer	
2024-03-27	[Review] Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine	Sara Cajander, Matthijs Kox, Brendon P Scicluna, Markus A Weigand, Raquel Almansa Mora, Stefanie B Flohé, Ignacio Martin-Loeches, Gunnar Lachmann, Massimo Girardis, Alberto Garcia-Salido, Frank M Brunkhorst, Michael Bauer, Antoni Torres, Andrea Cossarizza	